Pfizer, Thermo Fisher Among 200 Companies Warned by FTC Over Deals.

PFIZER Inc. 001326495 PFE

The US Federal Trade Commission (FTC) has sent warning letters to over 200 companies, including Pfizer, Baxter International, and Thermo Fisher Scientific, informing them that their acquisitions could still be challenged even after the deadline for the agency's antitrust review has passed. The letters were sent between June 2021 and July 2022 and were obtained through a Freedom of Information Act lawsuit. The practice of sending these letters was adopted by the FTC after Lina Khan became the agency's leader. The letters have sparked controversy, with some claiming they are intended to discourage legitimate merger activity. However, the FTC has not sought to break up any of the mergers by companies that received warning letters. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)